Advertisement

Binding of Insulin-like Growth Factor-1 to Erythrocytes in Children with Thalassemia

  • M. Theochari
  • L. Stamogiannou
  • A. Kafourou
  • E. Spanos
  • H. Nounopoulos
  • A. Bouloukos
  • C. S. Bartsocas

Abstract

Short stature is a common feature of children with thalassemia [1–5]. Several studies have shown that when patients with thalassemia approach puberty they present a significant delay of growth [6, 7].

Keywords

Growth Hormone Thalassemia Major Thalassemic Child Lipoatrophic Diabetes Somatomedin Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kuo B, Zains E, Roginsky M (1968) Endocrine function in thalassemia major. J Clin Endocrinol Metab 28: 805–808PubMedCrossRefGoogle Scholar
  2. 2.
    Lassmann MN, O’Brien RT, Pearson HA, Wise JK, Donabedian RK, Felig P, Genel M (1974) Endocrine evaluation in thalassemia major. Ann NY Acad Sci 232: 226–237CrossRefGoogle Scholar
  3. 3.
    Saenger P, Schwartz E, Markenson AL, Graziano JH, Levine LS, New MT, Hilgartner MW (1980) Depressed serum somatomedin activity in β-thalassemia. J Pediatr 96: 214PubMedCrossRefGoogle Scholar
  4. 4.
    Gabutti V, Piga A, Davico S et al. (1985) Evaluation and prevention of iron overload in thalassemic children. In: Sirchia G, Zanella A (eds) Thalassemia today. Centro Transfusionale Ospedale Maggiore Policlinico di Milano, Milan pp 95–100Google Scholar
  5. 5.
    Kattamis C, Liakopoulou T, Kattamis A (1990) Growth and development in children with thalassemia major. Acta Paediatr Scand [Suppl] 366: 111–117CrossRefGoogle Scholar
  6. 6.
    Modell B, Berdoukas V (1984) The clinical approach to thalassemia. Grune and Stratton, LondonGoogle Scholar
  7. 7.
    Borgna-Pignatti C, De Stefano P, Zonta L et al. (1985) Growth and puberty in thalassemia major. In: Sirchia G, Zanella A (eds) Thalassemia today. Centro Transfusionale Ospedale Maggiore Policlinico di Milano, Milan, 89–92Google Scholar
  8. 8.
    Werther GA, Matthews RN, Burger HG, Herington AC (1981) Deficiency of non-suppressible insulin-like activity in thalassemia major. Arch Dis Child 56: 855–859PubMedCrossRefGoogle Scholar
  9. 9.
    Herington AC, Werther GA, Matthews RN, Burger HG (1981) Studies on the possible mechanism for deficiency of nonsuppressible insulin–like activity in thalassemia major. Endocrinol Metab 52: 393–398CrossRefGoogle Scholar
  10. 10.
    Canale VC, Steinherz P, New MJ, Erlandson M (1974) Endocrine function in thalassemia major. Ann NY Acad Sci 232: 333–345PubMedCrossRefGoogle Scholar
  11. 11.
    Postel-Vinay MC, Girot R, Leger J, Hocquette JF, McKelvine P, Amar-Costesec A, Rappaport R (1989) No evidence for a defect in growth hormone binding to liver membranes in thalassemia major. Endocrinol Metab 68: 94–98CrossRefGoogle Scholar
  12. 12.
    Philips LS, Vassilopoulou-Sellin R (1980) Somatomedins. II N Engl J Med 302: 438–446CrossRefGoogle Scholar
  13. 13.
    Stamogiannou L, Siondi E, Kafourou A, Siafas K, Bouloukos T, Bartsocas C (1991) Receptors of SM-C in erythrocytes in children with thalassemia. 29th Panhellenic Pediatric Congress, May, 25-26 CreteGoogle Scholar
  14. 14.
    Boyum (1980) Separation of leukocytes from blood and bone marrow. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Invest 21 [Suppl] 97: 77–89Google Scholar
  15. 15.
    Wajchenberg BL, Lerario AC, El-Andere W, Ohunuma LY, Toledo E, Souza JT (1984) Human erythrocyte insulin receptors in normal male and female subjects. Clin Endocrinol (Oxf) 20: 23–30CrossRefGoogle Scholar
  16. 16.
    Philips LS, Herington AC, Karl IE, Daughaday WH (1976) Comparison of somatomedin activity in perfusates of normal and hypophysectomized rat livers with and without added growth hormone. Endocrinology 98: 606–614CrossRefGoogle Scholar
  17. 17.
    Schalch DS, Heinrich VE, Drazin B, Johnson CJ, Miller LL (1979) Role of the liver in regulating somatomedin activity: hormonal effects on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated prefused rat liver. Endocrinology 104: 1143–1151PubMedCrossRefGoogle Scholar
  18. 18.
    Hintz RL, Suskind R, Amatayakul K, Thanangkul O, Olson R (1978) Plasma somatomedin and growth hormone values in children with protein–calorie malnutrition. J Pediatr 92: 153–156PubMedCrossRefGoogle Scholar
  19. 19.
    Takano K, Hall K, Kastru KW, Hizuka N, Shizume K, Kawai K, Akimoto M, Takumo T, Sugino N (1979) Serum somatomedin A in chronic renal failure. J Clin Endocrinol Metab 48: 371–376PubMedCrossRefGoogle Scholar
  20. 20.
    Nissley SP, Rechler MM (1984) Somatomedin /insulin-like growth factors tissue receptors. Clin Endocrinol Metab 13: 43–47PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • M. Theochari
  • L. Stamogiannou
  • A. Kafourou
  • E. Spanos
  • H. Nounopoulos
  • A. Bouloukos
  • C. S. Bartsocas

There are no affiliations available

Personalised recommendations